Renowned Biotech Leader to Contribute Expertise in Neuroscience and Therapeutics Development New York, NY, September 30, 2024 – PRISM MediaWire – Klotho Neurosciences, Inc. (NASDAQ: KLTO), a cutting-edge biotechnology company focused on developing innovative therapies for neurodegenerative diseases and promoting healthy longevity, is proud to announce that Dr. Robert Langer, co-founder of Moderna, has joined … Continue reading “Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)”
Breaking News
Globe Small Cap Research Releases Company Report: SMC’s ChainTrade Platform Poised to Revolutionize Capital Markets’ Data Intelligence
BOCA RATON, FL, September 27, 2024 – PRISM MediaWire – SMC Entertainment, Inc. (“SMC” or…
DRYWORLD Teams Up with Spartan Race to Revolutionize Performance Apparel in Adventure Racing
Cutting-Edge Gear to Empower Athletes in the Ultimate Endurance Challenge Strategic Alliance Unites Innovation and…
The Awareness Group (TAG) Launches Game-Changing TAG Financial Services (TFS)
Strategic Acquisition of Southwest Financial Services Creates a Dynamic New Fintech Subsidiary for Project Financing…
LuxUrban Hotels Inc. Reports Second Quarter 2024 Financial Results
Miami, Florida, September 25, 2024 – PRISM MediaWire – LuxUrban Hotels Inc. (Nasdaq: LUXH), a…
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month
NEW YORK, September 25, 2024 – PRISM MediaWire – PRISM MarketView presents an exclusive Q&A…
LuxUrban Hotels to Host Webcast to Review the Financial Results for the Second Quarter of 2024
Conference Call and Webcast to be held on September 25, 2024 at 5:00 PM ET…
Premier Graphene Receives Confirmatory Concrete and Mortar Test Results from Global Leader in Sustainable Construction
Global Leader Nears Final Testing Phase Which Could Lead to Long-Term Supply Agreements El Centro,…
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
PITTSBURGH, Sept. 24, 2024 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or…
The Awareness Group (TAG) Outlines Unique Growth Strategy For Commercial and Residential Solar Development Financing and Projects
Scottsdale, AZ, September 24, 2024 – PRISM MediaWire – The Awareness Group (OTC: FHLD) (“TAG”), an emerging…
Allied Energy Corporation (OTC: AGYP) Announces Operational Launch of Sloan Petroleum and Enerhash USA Project, Paving the Way for Future Growth
CARROLLTON, TX, September 23, 2024 – PRISM MediaWire – Allied Energy Corporation (OTC: AGYP) announces that…
Digital Utilities Ventures Reports Strong Fiscal Year 2024 – Advancing Leadership in Green Technologies
MANKATO, MN, September 23, 2024 – PRISM MediaWire – Digital Utilities Ventures, Inc. (OTC: DUTV),…
Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System
Fort Lauderdale, FL., September 23, 2024 – PRISM MediaWire – SS Innovations International, Inc. (the…
HOLIDAY ISLAND HOLDINGS, INC. SHIFTS ITS PRIMARY FOCUS TO ITS METCALF WELLS
Plant City, Florida, September 20, 2024 – PRISM MediaWire – Holiday Island Holdings, Inc. (OTC:…
